SavedAdd your journal

Journals / Current Research in Dental Sciences / 2015 / Supplement 12

ORAL SURGICAL PROCEDURES IN PATIENTS WITH OSTEOPOROSIS

OSTEOPOROZ HASTALARINDA ORAL CERRAHİ UYGULAMALAR

Duygu OFLUOĞLU
Sertan ERGUN
Pages
140–148
Publication Date
2015-11-24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review is focused on the particular points of the oral and maxillofacial surgical procedures including dental implant procedures in patients with osteoporosis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteoporosis is a progressive systemic bone disease that is characterized by an increase in fragility, decreased bone volume and risk of fracture.
📊
Key Findings & Data:The most important complication of osteoporosis on oral and maxillofacial components is the decrease in bone mass and density and periodontitis.
💡
Conclusion & Impact:This review is focused on the particular points of the oral and maxillofacial surgical procedures including dental implant procedures in patients with osteoporosis
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Osteoporoz · oral cerrahi uygulamalar · dental implant

Abstract

Osteoporosis is a progressive systemic bone disease that is characterized by an increase in fragility, decreased bone volume and risk of fracture. It affects the cancellous part of the bone as well as its cortical part. The most important complication of osteoporosis on oral and maxillofacial components is the decrease in bone mass and density and periodontitis. There is no definitive contraindication associated with maxillofacial surgical procedures in this group of patients; almost all of the related surgical procedures could be applied if the suitable circumstances will be ensured. This review is focused on the particular points of the oral and maxillofacial surgical procedures including dental implant procedures in patients with osteoporosis

Özet

Osteoporoz, ilerleyici karakterde bir sistemik kemik hastalığı olup, artmış frajilite, düşük kemik kütlesi ve kırık riski ile karakterizedir. Osteoporoz, hem kortikal hem de kansellöz kemiğin yapısını etkilemektedir. Osteoporozun oral ve maksillofasiyal yapılar üzerine olan en önemli etkileri; kemik hacmi ve dansisitesinde azalma ile periodontitistir. Bu hasta grubunda oral ve maksillofasiyal cerrahi işlemler için kesin kontraendikasyon bulunmamakla beraber, uygun durum ve koşulların sağlanarak pre- ve postoperatif dönemde komplikasyondan uzak sonuçlar elde edilebilir. Bu derlemede, osteoporozlu hastalarda dental implant uygulamaları da dahil olmak üzere oral ve maksillofasiyal cerrahi işlemlerde dikkat edilmesi gereken hususlar derlenmiştir.

🔖

Cite This Article

OFLUOĞLU, D., ERGUN, S. (2015). ORAL SURGICAL PROCEDURES IN PATIENTS WITH OSTEOPOROSIS. Current Research in Dental Sciences, Supplement 12, 140–148. https://ajindex.com/articles/735959

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Şahin M, Demirağ NG. Osteoporoz. Türk Ortopedi ve Travmatoloji Birliği Derneği Dergisi 2004;3:1-2. National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis, Osteoporos Int 1998;8:1-88. Christiansen C: Skeletal osteoporosis. J Bone Miner Res 1993;8 Suppl 2:475-80. White SC. Oral radiographic predictors of osteoporosis. Dentomaxillofac Radiol 2002;31:84- 92. López-López J, Estrugo-Devesa A, Jane-Salas E, Ayuso-Montero R, Gómez-Vaquero C. Early diagnosis of osteoporosis by means of orthopantomograms and oral x-rays. a systematic review. Med Oral Patol Oral Cir Bucal 2011;16:905- 13. Díaz-Correa LM, Ramírez-García LM, Castro- Santana LE, Vilá LM. Osteoporosis knowledge in patients with a first fragility fracture in Puerto Rico. Bol Asoc Med 2014;106:6-10.
  2. Dunn, J.C. Risedronate: a review of its pharmacological properties and clinical use in resobtive bone disease. Drugs 2001;61:685-712.
  3. Ettinger, B. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999;282:637-45.
  4. Khan A, Fortier M; Menopause and Osteoporosis Working Group, Fortier M, Reid R, Abramson BL, Blake J, Desindes S, Dodin S, Graves L, Guthrie B, Johnston S, Khan A, Rowe T, Sodhi N, Wilks P, Wolfman W. Osteoporosis in menopause. J Obstet Gynaecol Can 2014;36:839-40. Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288: 321-33.
  5. Inagaki K, Kurosu Y, Kamiya T, Kondo F, Yoshinari N, Noguchi T, Krall EA, Garcia RI. Low metacarpal bone density, tooth loss, and periodontal disease in Japanese women. J Dent Res 2001;80:1818-22.
  6. Mogi M, Otogoto J, Ota N, Inagaki H, Minami M, Kojima K. Interleukin 1 beta, interleukin 6, beta 2- microglobulin, and transforming growth factor- alpha in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 1999;44:535-9.
  7. Mohammad AR, Hooper DA, Vermilyea SG, Mariotti A, Preshaw PM. An investigation of the relationship between systemic bone density and clinical periodontal status in post-menopausal Asian- American women. Int Dent J 2003;53:121-5.
  8. Yoshihara A, Seida Y, Hanada N, Miyazaki H. A longitudinal study of the relationship between periodontal disease and bone mineral density in community-dwelling older ad